New gut damage test could help ICU doctors spot hidden injury
NCT ID NCT07440368
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at a protein called I-FABP, which is released when gut cells are damaged. Researchers will measure it in the blood and urine of 500 ICU patients to see if it relates to how severe their gastrointestinal problems are. No treatments are given—this is purely to gather information and improve how doctors assess gut health in critical illness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more objective way to diagnose and grade gut injury in critically ill patients, improving care.
- What could go wrong
- This is an observational study, so it won't test any treatment. The biomarker may not prove useful in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What does a healthy mouth mean for people with disabilities?
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- New drug duo takes on recurrent brain cancer
- Spinach showdown: does how It's grown affect your blood pressure?
- Video instruction may cut medication errors in kidney transplant patients
- Bone marrow secrets could predict chemo success in leukemia